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Abstract
Background: Cell adhesion molecules (CAMs) are essential for maintaining tissue integrity by regulating
intercellular and cell to extracellular matrix interactions. Cadherins and catenins are CAMs that are located on the
cell membrane and are important for adherens junction (AJ) function. This study aims to verify if
hypercholesterolemic diet (HCD) or bladder outlet obstruction (BOO) promotes structural bladder wall modifications
specific to alterations in the expression of cadherins and catenins in detrusor muscle cells.
Methods: Forty-five 4-week-old female Wistar rats were divided into the following three groups: group 1 was a
control group that was fed a normal diet (ND); group 2 was the BOO model and was fed a ND; and group 3 was a
control group that was fed a HCD (1.25% cholesterol). Initially, serum cholesterol, LDL cholesterol and body weight
were determined. Four weeks later, groups 1 and 3 underwent a sham operation; whereas group 2 underwent a
partial BOO procedure that included a suture tied around the urethra. Six weeks later, all rats had their bladders
removed, and previous exams were repeated. The expression levels of N-, P-, and E-cadherin, cadherin-11 and
alpha-, beta- and gamma-catenins were evaluated by immunohistochemistry with a semiquantitative analysis.
Results: Wistar rats fed a HCD (group 3) exhibited a significant increase in LDL cholesterol levels (p=0.041) and
body weight (p=0.017) when compared to both groups that were fed a normal diet in a ten-week period. We
found higher β- and γ-catenin expression in groups 2 and 3 when compared to group 1 (p = 0.042 and p = 0.044,
respectively). We also observed Cadherin-11 overexpression in group 3 when compared to groups 1 and 2
(p = 0.002).
Conclusions: A HCD in Wistar rats promoted, in addition to higher body weight gain and increased serum LDL
cholesterol levels, overexpression of β- and γ-catenin in the detrusor muscle cells. Similar finding was observed in
the BOO group. Higher Cadherin-11 expression was observed only in the HCD-treated rats. These findings may be
associated with bladder dysfunctions that occur under such situations.
Keywords: Cell adhesion molecules, Bladder dysfunction, Hypercholesterolemic diet, Bladder outlet obstruction
* Correspondence: docjpjr@uol.com.br
1Laboratory of Medical Investigation – LIM 55, Urology Department,
University of São Paulo Medical School, São Paulo, Brazil
2Universidade Nove de Julho, São Paulo, Brazil
© 2013 Pontes-Júnior et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Pontes-Júnior et al. BMC Urology 2013, 13:50
http://www.biomedcentral.com/1471-2490/13/50
Background
Bladder dysfunction is a syndromic diagnosis with several
causes and different clinical presentations. It usually causes
symptoms that affect patient quality of life, can occur at
any age in both sexes and is pathologically characterised by
the existence of abnormal bladder contraction or relaxation.
This condition is not uncommon; it was estimated that
more than a third of the United Kingdom population older
than 40 years have an overactive bladder diagnosis [1].
The pathophysiological mechanism of bladder dysfunc-
tion is not well understood; however bladder outlet ob-
struction (BOO), metabolic diseases, neurologic conditions,
inflammation and aging probably have an important role.
In addition, accumulating data in the literature indicates
that structural and interaction changes between detrusor
smooth muscle cells are important in bladder dysfunction
pathogenesis. Supporting this concept, a dysfunctional pat-
tern of muscle fibres that are caused by loss of intercellular
adhesion has been demonstrated to be the morphological
correlation of a hyperactive detrusor or an obstructed blad-
der [2,3]. BOO is a prevalent condition associated with
bladder dysfunction and if not properly treated may lead to
irreversible fibrosis in bladder wall [4].
Hypercholesterolemia is a risk factor in many cardio-
vascular diseases and may also affect the genitourinary
tract. Corroborating this notion, Son et al. demonstrated
correlation between hypercholesterolemia and detrusor
overactivity in experimental model [5]. Our group evalu-
ated the collagen composition of bladder wall in two rat
models of BOO and hypercholesterolemia and found
that both groups had the same morphological alterations
regarding thin collagen fibers and the amounts of type
III collagen expressed when compared to the control
group; indicating that despite the different physiopathol-
ogy, some molecular changes in BOO may be similar to
that observed in metabolic diseases [6]. However, up to
now the complete pathogenesis of bladder dysfunction
secondary to metabolic disease and obstruction in
humans is not defined.
The cellular basis of bladder contraction is not an
independent mechanism but rather a result of a group
of functional components of smooth muscle cells and
their extracellular matrices that act cooperatively with
myofibroblasts to contract or relax. Therefore, proper
intercellular adhesion and communication, which are re-
lated to cell adhesion molecule (CAM) expression, are
required for normal bladder function.
It is acknowledged that interaction between detrusor
smooth muscle cells and myofibroblasts, coupled via gap
junctions, is required for coordinated and synchronised
detrusor contraction. However, the sole interaction pro-
moted by gap junctions is insufficient to ensure an opti-
mal contraction; stronger intercellular adhesions such as
adherens junctions (AJs) are necessary to avoid breaking
muscle bundles during contraction and to assure gap
junction functioning. The protein composition of AJs is
mainly comprised of CAMs, especially catenins and
cadherins.
Cadherins are transmembrane calcium-dependent pro-
teins that regulate homotypic intercellular adhesion. The
intracellular domain is anchored to the cytoskeleton
through a complex of alpha-, beta- and gamma-catenins,
whereas the extracellular portion is connected with the
extracellular domain of adjacent cell’s cadherin. The
cadherin-catenin complex is essential for AJs; moreover,
expression of the entire complex in detrusor muscle
cells is necessary for proper contraction.
E-cadherin is commonly expressed in the AJ in epithelial
tissue. Regarding the cadherin that is expressed in smooth
muscle cell, the scarce literature indicates that cadherin-11
is the probable candidate [7]. Kuijpers et al. observed
cadherin-11 expression in detrusor smooth muscle cells in
biopsies from radical cystectomy specimens, suggesting that
it is important for adhesion between detrusor smooth
muscle cells and myofibroblasts, which is required for a co-
ordinated bladder contraction [8].
If the cadherin-11-catenin complex is necessary for
physical coupling of detrusor muscle cells and coordi-
nated bladder contractions [8], one can theorise that
pathological conditions that interfere with bladder
homeostasis may be associated with disturbance of this
complex, but to date the literature regarding CAM ex-
pression is insufficient to define their role in bladder
dysfunction pathogenesis. We theorize that CAM ex-
pression changes in detrusor muscle cells may represent
the molecular basis of bladder dysfunction. This study
aims to verify if (HCD) or (BOO) promote structural
bladder wall modifications specific to cadherin and
catenin expression level changes in detrusor muscle
cells.
Methods
Experimental protocol
We prospectively evaluated forty-five 4-week-old female
Wistar rats that were divided into the following three
groups consisting of 15 rats each: group 1 was a control
group and was fed a normal diet (ND); group 2 was the
BOO model and was fed a ND; and group 3 was a control
group and was fed a HCD (1.25% cholesterol diet). The
HCD model in rats employed in our study was earlier de-
scribed by Nunes et. al. [6]. Initially, serum levels of choles-
terol, LDL cholesterol and body weight were determined.
Four weeks later, group 2 underwent a partial BOO proced-
ure, whereas groups 1 and 3 underwent a similar sham
operation.
The partial BOO procedure was also previously described
[9]. Briefly, under general anaesthesia, the skin was shaved,
prepped with an iodine/alcohol mixture and a low midline
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longitudinal incision was made. The urethra was circumfer-
entially dissected and released from the surrounding
periurethral tissue to enable the confection of the BOO
procedure. In groups 1 and 3, the procedure was concluded
at this time. In group 2, an unabsorbed 5–0 nylon suture
was passed and tied loosely around the urethra with a 22G
needle inside, leaving approximately 1 mm of residual ur-
ethral lumen [9].
All groups were still fed their particular diet (groups 1
and 2 with the normal diet and group 3 with the HCD).
Six weeks later, for a total of ten weeks of study, choles-
terol, LDL cholesterol and body weight were reassessed.
Subsequently, all of the rats were euthanised in a CO2
chamber and had their bladders removed. We chose 6
weeks after the BOO procedure because this was the
time necessary to cause changes in detrusor muscle cells
secondary to the partial outlet obstruction [6,9]. An
open full bladder wall thickness biopsy was performed
to provide tissue for CAM expression analysis, and after
fixation, the tissue was embedded in paraffin.
Expression levels of N-, P-, and E-cadherin; cadherin-11;
and α-, β- and γ-catenins were evaluated through immuno-
histochemistry by the same uropathologist, (KRML), and
semiquantitative analyses were performed for all of the anti-
bodies. The expression was divided into four groups
according to the staining intensity as follows: 0 rep-
resenting negative staining, 1 representing weak staining, 2
representing intermediate staining and 3 representing
strong staining. In Figure 1, we present examples of the
semiquantitative analysis employed in the study.
It was previously demonstrated that normal epithelial
and mesenchymal cells display diffusely strong expres-
sion of the Cadherin-catenin complex molecules at cell
membrane or cytoplasm [10,11]. For that reason and as
described by others [11], in our study the CAM expres-
sion was considered as higher when the staining was
strong and diffusely present in more than 70% of the de-
trusor muscle cells evaluated and lower when the stain-
ing was below that value.
Immunohistochemistry
Histological examinations of the specimens were performed
in formalin-fixed and paraffin-embedded sections that were
stained with haematoxylin and eosin. The samples under-
went a heat-induced antigen retrieval process using citrate
buffer (1 mM, pH 6.0). The slides were incubated overnight
at 4°C with a specific monoclonal antibody. The LSAB sys-
tem was used for the immunostaining (Dako Cytomation,
CA). Colour was developed through a reaction with a 3,3′-
diaminobenzidine substrate-chromogen solution followed
by counterstaining with Harris haematoxylin. The slides
were dehydrated, coverslipped and observed under a light
microscope. The specific antibodies and their respective di-
lutions are listed in Table 1.
Figure 1 Examples of the four categories of the CAM expressions semiquantitative analysis’ semiquantitative analysis through
immunohistochemistry used in the study: examples of absent (A), weak (B), intermediate (C) and strong (D) expression of cadherin-11
in detrusor muscle cells; magnification 400x.
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Statistical analyses were performed using SPSS version
12.0 software for Windows. The metabolic changes were
evaluated through the ANOVA model with repeated
measure. We compared CAM expressions between the
three groups with the generalisation of Fisher’s exact test
and chi-square test; post hoc analysis with Bonferroni
correction was used to test the differences between each
group and p < 0.05 was considered statistically signifi-
cant. Approval for the study was given by the Institu-
tional Board of Ethics of our (CAPPesq - Comissão de
Ética para Análise de Projetos de Pesquisa do
HCFMUSP nº1074/04). The animals received humane
care in compliance with the Guide for care and use of la-
boratory animals (NIH Publication 85–23, revised 1985).
Results
One rat from group 2 developed urinary retention due to
excessive tension applied during the BOO procedure and
was excluded from the study, the remaining 44 rats com-
pleted the protocol for CAM expression analysis.
To compare the metabolic changes according to diet
type, the ND-treated rats in groups 1 and 2 were combined
and compared with the HCD-treated group (group 3).
Twelve rats from groups 1 and 2 were excluded from this
analysis because of loss of data due to storage problems. All
biochemical and weight gain parameters are summarised in
Table 2. From the start point we see that HCD group shows
the same total cholesterol, LDL levels and body weight than
controls, the p-values observed were 0.462, 0.368 and
0.196, respectively.
After the ten-week study, the HCD cases exhibited a sig-
nificant increase of LDL cholesterol levels and body weight
when compared to rats fed a ND (groups 1+2) (p=0.041).
The average weight gain in HCD group was 187.0 ± 8.2 g
compared to 156.6± 8.2 g in controls (p=0.017). No differ-
ence was found in the serum total cholesterol levels be-
tween the rats fed and HCD or ND.
For CAM expression analysis, all groups were compared
independently, and all rats, excluding 1 from group 2, were
considered. The expressions of N-, P-, and E-cadherin and
cadherin-11 were detected in cytoplasmic cell membrane,
whereas alpha-, beta- and gamma-catenins were expressed
in both the cytoplasm and cell membrane. The number
and percentage of cases with higher expression for each
CAM is depicted in Table 3.
The global comparison of Cadherin-11 expression
among the 3 groups was statistically significant
(p=0.003). At post-hoc analysis we found that the differ-
ence was due the higher Cadherin-11 expression in
HCD group when compared to control and BOO groups
(p=0,002). Cadherin-11 expression was also higher in the
BOO group when compared with group 1 (35 vs. 20%);
however the difference was not significant (p=0.4270).
The β-catenin expression in global comparison was
also statistically significant (p=0.049). At post-hoc ana-
lysis we observed that HCD and BOO groups were simi-
lar (p>0.999). The β-catenin expression was higher in
Table 1 Antibodies and their respective dilutions
Antibody Manufacturer Dilution
E-Cadherin Dako, CA, USA 1:50
β-Catenin BD, NJ, USA 1:50
γ-Catenin Zymed, CA, USA 1:100
α-Catenin Santa Cruz, CA, USA 1:100
Cadherin-11 Invitrogen, CA, USA 1:50
N-Cadherin Dako, CA, USA 1:50
P-Cadherin Abcam, Cambridge, UK 1:20
Table 2 Total cholesterol, LDL cholesterol and body
weight values in 32 Wistar rats stratified by diet type
Time
t = 0 10 weeks p-value
Total cholesterol (mg/mL)
Normal diet 80.9 ± 3.8 87.6 ± 2.1 0.288
HC diet 85.7 ± 6.3 91.0 ± 5.5 0.427
p-value 0.462 0.376
LDL cholesterol (mg/mL)
Normal diet 48.4 ± 2.8 48.2 ± 2.1 0.964
HC diet 53.7 ± 5.8 70.9 ± 5.3 0.007
p-value 0.368 0.041
Body weight (g)
Normal diet 83.2 ± 3.7 239.8 ± 7.2 <0.001
HC diet 94.5 ± 4.3 281.5 ± 7.8 <0.001
p-value 0.196 0.017
The data were expressed by mean ± standard error.
Table 3 Number and percentage of cases with higher
CAM expression values in 45 female Wistar rats are
stratified as follows: group 1, control fed a ND; group 2,
BOO-treated model fed a ND and group 3) control fed a
HCD
Group 1 Group 2 Group 3
CAM Control BOO HCD p value
N° (%) N° (%) N° (%)
E-Cadherin 6 (40.0%) 6 (42.9%) 5 (33.3%) 0.3931
N-Cadherin 0 3 (21.4%) 5 (33.3%) 0.0562
P-Cadherin 1 (6.7%) 0 4 (26.6%) 0.1692
Cadherin-11 3 (20.0%) 5 (35.7%) 12 (80.0%) 0.0031
β-Catenin 2 (20.0%) 8 (66.7%) 5 (71.4%) 0.0492
α-Catenin 4 (40.0%) 7 (58.3%) 3 (42.9%) 0.7172
γ-Catenin 1 (10.0%) 6 (50.0%) 4 (57.1%) 0.0842
1Chi-square test 2Generalisation of Fisher’s exact.
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HCD and BOO groups when compared to controls
(p=0.042).
The γ-catenin expression among the 3 groups only
reaches marginally significance (p=0.084). The expression
was similar between HCD and BOO groups (p>0.999);
however γ-catenin expression was significatively higher in
BOO and HCD groups when compared to controls
(p=0.044). We did not find any differences in expression
amongst the groups for the following CAMs: E-cadherin,
N-cadherin, P-cadherin or alpha-catenin.
Discussion
This is the first study in the literature to demonstrate
that a HCD or the presence of BOO in Wistar rats was
associated with increased beta- and gamma-catenins ex-
pression levels in detrusor smooth muscle cells. We also
observed increased cadherin-11 expression in HCD
group when compared to BOO and control groups. We
hypothesise that these pathological conditions cause de-
trusor homeostasis disruption and that the molecular re-
sponse to this condition is reflected by altered CAM
expression in order to improve the mechanically coup-
ling of muscle cells and detrusor contraction.
In normal epithelial tissues, mechanical cell coupling
is dependent on an AJ, which mediates the adhesion of
cells to their neighbours or to the extracellular matrix.
The AJs are located at the plasma membrane and are
mainly formed by CAMs that anchor cytoskeletal myo-
filaments to the cell membrane [12,13]. It has been dem-
onstrated that the AJ is also the predominant structure
responsible for detrusor smooth muscle cell coupling.
Carey et al. determined immunohistochemically that the
entire cell membrane of normal detrusor smooth muscle
cells exhibited the presence of AJs [14]. If AJs are essen-
tial for mechanical detrusor muscle coupling in physio-
logical conditions, a similar importance was also
demonstrated for them in dysfunctional bladders [15].
Smooth muscle cells in the bladder wall are me-
chanosensitive, which enables them to respond to the
mechanical stretch stress that occurs after BOO. The
smooth muscle cells undergo modifications of gene expres-
sion and protein synthesis that cause a hypertrophic state
that is necessary to increase intravesical pressure, overcome
BOO and result in micturition. Although the physiopatho-
logical mechanism whereby BOO causes urinary symptoms
is not clear, several morphologic and functional modifica-
tions of the bladder detrusor muscle cells have been de-
scribed in BOO patients that could play a direct role in
determining voiding dysfunction and symptoms [16]. Be-
cause cells must be extensively connected both electrically
and structurally to produce coordinated contractions [17],
we theorise that the modifications observed n BOO pa-
tients may be related, in part, to changes in CAM
expression.
Cadherin-11, also known as osteoblast-cadherin, belongs
to the type 2 cadherin subgroup and is a marker of the
connected cells of the mesenchyme. We supposed that the
molecular change necessary to increase smooth muscle
contractions in BOO cases would be the higher Cadherin-
11 expression. Corroborating the role of cadherin-11 in
bladder dysfunction, Roosen et al. evaluated CAM expres-
sion using immunohistochemistry in 32 patients with
DO and observed co-localisation of cadherin-11 and beta-
catenin in detrusor and myofibroblast cells and
upregulation of cadherin-11 in the suburothelium [18].
Roosen et al. concluded that these CAM might have a sig-
nificant role in overactive bladder pathogenesis [18].
The same mechanism may be postulated for HCD-
treated rats, as higher cadherin-11 and catenins levels
were also found in this group. The observation of higher
cadherin-11 expression in 80% of HCD rats indicates
that this is the cadherin that maintain the cadherin-
catenin complex in detrusor. If one acknowledges that
HCD is associated with a loss of detrusor muscle cells,
increases in fibroblastic cells and collagen deposition
due chronic ischemia, the higher expression of proteins
of the cadherin-catenin complex in such condition
would represent a compensatory effort to recover
muscle contraction. In a previous report, using the same
methodology employed in the present article, we dem-
onstrated that BOO and HCD groups exhibited similar
higher expression of thin collagen fibers and type III col-
lagen when compared to controls, indicating that, des-
pite the different physiopathology, both conditions share
some molecular changes at bladder wall [6]. Supporting
this hypothesis, Nomiya et al. also demonstrated in-
creased bladder activity characterized by higher reflex
bladder contraction in a rat model of atherosclerosis-
induced chronic bladder ischemia [19].
In our study, Cadherin-11, beta- and gamma-catenins
expression were higher in BOO group when compared
to controls, however it reached significance only for the
beta and gamma catenins. This molecular finding may
enable better contraction by improving communication
between smooth muscle cells and myofibroblasts and by
increasing adhesion between detrusor muscle cells, as
these catenins play a pivotal role in AJ that is critical for
cell-cell coupling.
The three catenins connect and anchor the cadherin
at the cell membrane to the cytoskeletal actin and are
essential for cell-cell adhesion. A loss of catenin, despite
normal cadherin expression, compromises the adhesion
complex. Supporting this concept, it has been demon-
strated that expression of alpha- and beta-catenin, in
addition to cadherin, is required for adequate cardiac
muscle cell contraction in rats [20]. In our study, we ob-
served significant increases in beta- and gamma-catenin
levels in the BOO- and HCD-treated groups compared
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with the control group. The increased levels of almost
all proteins of the cadherin-catenin complex in detrusor
muscle cells of BOO- or HCD-treated rats may indicate
a tendency to preserve cell adhesion that is essential for
smooth cell contraction.
The role of CAM in bladder dysfunction is also
emphasised by studies in geriatric patients in which reduc-
tions of AJ were commonly observed in DO and BOO pa-
tients. Elbadawi et al. evaluated 35 elderly patients with
bladder dysfunction that was characterised by DO, and by
employing electron microscopy, they found a distinctive
disjunction structural pattern that was characterised by
moderately widened intercellular spaces and scarce inter-
mediate muscle cell junctions [21]. Other studies on the
geriatric population affected by BOO or DO also found re-
ductions of junctions between detrusor muscle cells
[22,23]. We believe that these histological dysfunctional
findings reflect the phenotype associated with changes in
CAM expression.
Kuijipers et al. evaluated CAM expression through im-
munofluorescence in bladder biopsies from eight radical
cystectomy specimens and found an absence of E-cadherin
and gamma- and alpha-catenins and the presence of
cadherin-11 and beta-catenin in detrusor muscle cells [8].
In accordance with our conclusion, Kuijipers et al. postu-
lated that cadherin-11 may have an important role in nor-
mal bladder contraction by connecting smooth detrusor
muscle cells and myofibroblasts, which is necessary for nor-
mal bladder contraction.
In our series, we also observed reduced E-cadherin ex-
pression in the majority of the cases regardless the group;
this finding is expected because this CAM is usually
expressed in epithelial tissues. The difference between
Kuijipers’ analysis and our study concerning alpha- and
gamma-catenins expression levels may be explained by the
different tissues evaluated in these series. The former study
evaluated normal bladder tissue adjacent to bladder cancer,
whereas ours focused on normal rat bladder tissue.
A previous study published by Wagener et al., in con-
trast to ours, reported that no cadherin or catenin ex-
pression levels were observed by immunohistochemistry
in the detrusor muscle cells of DO and BOO patients,
and concluded that such CAMs are not involved in
smooth muscle cell adhesion in these pathological con-
ditions [23]. This disparity may be explained by the em-
ployment of a polyclonal pan-cadherin antibody,
whereas in our analysis, we used monoclonal specific
antibodies against N-, P-, and E-cadherin and cadherin-
11. The time of CAM expression analyses is another dif-
ference between the protocols; our results reflect the
changes that occur at 10 weeks in rats, whereas the
former study evaluated chronic established pathological
conditions in human patients. CAM expression alter-
ations in detrusor muscle cells may represent an early
finding that is not captured when only chronic cases are
evaluated.
A limitation of our data is that we evaluated bladders
from rats; therefore, analysis of CAM expression in hu-
man bladders of BOO and dyslipidemic patients is ne-
cessary to ensure that these findings are applicable to
dysfunctional human bladder. In addition, the results of
the present study should be regarded as hypothesis gen-
erating; therefore, confirmatory studies employing quan-
titative methods of protein expression such as western
blotting or gene expression analysis through RT-PCR are
necessary to confirm our results.
Conclusions
A hypercholesterolemic diet in Wistar rats promoted, in
addition to higher body weight gain and an increased
serum LDL cholesterol level, the overexpression of β- and
γ-catenin in detrusor muscle cells, similar finding was
observed in the BOO group. Cadherin-11 overexpression
was observed only in the HCD-treated rats. These findings
may be associated with bladder dysfunctions that occur
under such situations.
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